Breast Cancer

	12/14/2009	Exemestane Therapy Show Unfavourable Changes in Lipid Profile: Presented at SABCS - (DGDispatch)
	12/14/2009	Bevacizumab Plus Docetaxel Improves Progression-Free Survival, but Not Overall Survival in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/14/2009	Adding Bevacizumab to Second-Line Chemo Improves Progression-Free Survival in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/14/2009	Switching to an Aromatase Inhibitor at Year 5 of Tamoxifen Therapy Reduces Breast Cancer Recurrence: Presented at SABCS - (DGDispatch)
	12/14/2009	Primary Tumour Resection Improves Outcomes in Advanced Breast Cancer: Presented at SABCS - (DGDispatch)
	12/14/2009	Soy food intake and breast cancer survival (JAMA)
	12/13/2009	ACE Inhibitors and ARBs May Protect Against Breast Cancer Recurrence: Presented at SABCS - (DGDispatch)
	12/13/2009	Neratinib/Paclitaxel Combination Shows Promise in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/13/2009	Long-Term Follow-Up Using PET-CT Can Help Detect Lymph Node Recurrence in Breast Cancer: Presented at SABCS - (DGDispatch)
	12/13/2009	Adjuvant Trastuzumab With Chemotherapy for 1 Year Delays Breast Cancer Progression: Presented at SABCS - (DGDispatch)
	12/12/2009	Whole Radiation Recommended for Mucinous Carcinoma: Presented at SABCS - (DGDispatch)
	12/12/2009	Docetaxel Plus Capecitabine Shows More Benefit as First-Line Therapy for Metastatic Breast Cancer Than Docetaxel Plus Epirubicin: Presented at SABCS - (DGDispatch)
	12/12/2009	No Survival Benefit for 5-FU/Docetaxel After Preoperative Epirubicin/Cyclophosphamide in Inflammatory Breast Cancer: Presented at SABCS - (DGDispatch)
	12/12/2009	Adding Bevacizumab to Second-Line Chemo Improves Progression-Free Survival in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/12/2009	Risks of Autologous Stem-Cell Transplantation Outweigh Benefits in Treating High-Risk Breast Cancer: Presented at SABCS - (DGDispatch)
	12/12/2009	Adding Lapatinib, Continuing Trastuzumab Despite Progression Adds Months to Breast Cancer Survival: Presented at SABCS - (DGDispatch)
	12/11/2009	Ibandronate Offers Pain Relief With Renal Safety in Women With Breast Cancer, Metastatic Bone Disease: Presented at SABCS - (DGDispatch)
	12/11/2009	Exemestane for 5 Years Not Superior to Tamoxifen Followed by Exemestane for Breast Cancer: Presented at SABCS - (DGDispatch)
	12/11/2009	No Cardiac Safety Problems When Casopitant Is Given With Anthracycline for Malignant Solid Tumours: Presented at SABCS - (DGDispatch)
	12/11/2009	High-Dose Fulvestrant Postpones Disease Progression in Advanced Breast Cancer: Presented at SABCS - (DGDispatch)
	12/11/2009	Lymphedema Continues to Appear Years After Breast Cancer Treatment: Presented at SABCS - (DGDispatch)
	12/11/2009	Pregnancy Does Not Worsen Outcomes Among Women With Breast Cancer: Presented at SABCS - (DGDispatch)
	12/11/2009	Optimal Duration of Neoadjuvant Letrozole Longer Than the Traditional 4 Months to Permit Breast-Conserving Surgery: Presented at SABCS - (DGDispatch)
	12/11/2009	Letrozole Superior to Tamoxifen in Hormone Receptor-Positive Early Breast Cancer: Presented at SABCS - (DGDispatch)
	12/11/2009	Febrile Neutropenia Occurs More Frequently in Real World Setting Than in Clinical Trials: Presented at SABCS - (DGDispatch)
	12/11/2009	Lapatinib Plus Nab-Paclitaxel Shows Promise for HER2-Positive Breast Cancer: Presented at SABCS - (DGDispatch)
	12/08/2009	TopAbstracts in Breast Cancer 12/08/2009 - (DGNews)
	12/06/2009	Elastography Can Help Distinguish Between Cancerous and Benign Skin Growths: Presented at RSNA - (DGDispatch)
	12/04/2009	Mammography May Increase Breast Cancer Risk in Some High-Risk Women - (DGNews)
	12/04/2009	Controversial US Government Mammography Guidelines Rapped by RSNA Expert Panel: Presented at RSNA - (DGDispatch)